Vancomycin resistance: Status quo and quo vadis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 10, 1999, Pages 683-690

  Endtz, H P ^a   Van Den Braak, N ^a   Verbrugh, H A ^a   Van Belkum, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

BACTERIAL GENETICS; BACTERIAL INFECTION; ENTEROCOCCUS; FOOD CONTAMINATION; GENOME; HOSPITAL INFECTION; HUMAN; MEAT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; VETERINARY MEDICINE;

EID: 0032727021     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050379     Document Type: Review

References (89)

1. 1. Nieto M, Perkins HR: Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. Biochemical Journal (1971) 123:773-787
2. 2. Rao J, Lahiri J, Isaacs L, Weiss RM, Whitesides GM: A trivalent system for vancomycin-D-Ala-D-Ala with higher affinity than avidin-biotin. Science (1998) 280:708-711
3. 3. French GL: Enterococci and vancomycin resistance. Clinical Infectious Diseases (1998) 27, Supplement 1:75-83
4. 4. Emori TG, Gaynes RP: An overview of nosocomial infections including the role of the microbiology laboratory. Clinical Microbiology Reviews (1993) 6:428-442
5. 5. McDonald LC, Kuehnert MJ, Tenover FC, Jarvis WR: Vancomycin-resistant enterococci outside the health care setting: prevalence, sources and public health implications. Emerging Infectious Diseases (1997) 3:311-317
6. 6. Martone WJ: Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infection Control and Epidemology (1998) 19:539-545
7. 7. Huyck MM, Sahm DF, Gilmore MS: Multiple drug resistant enterococci: the nature of the problem and an agenda for the future. Emerging Infectious Diseases (1998) 4:239-249
8. 8. Bates J: Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. Journal of Hospital Infection (1998) 37:89-101
9. 9. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ: Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. Journal of Infectious Diseases (1996) 173:1292-1294
10. 10. Sexton DJ: Rates of infectious diseases consultation in hospitals of different sizes and types, 1986-1987. Reviews of Infectious Diseases (1991) 13:527
11. 11. Edmond BD, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP: Vancomycin-resistant enterococcal bacteraemia: natural history and attibutable mortality. Clinical Infectious Diseases (1996) 23:1234-1239
12. 12. Boyce JM, Opal SM, Potter-Bynoe G, Laforge RG, Zervos MJ, Furtado G, Victor G, Medeiros AA.: Emergence and nosocomial transmission of ampicillin resistant enterococci. Antimicrobial Agents and Chemotherapy (1992) 36:1032-1039
13. 13. Moulin F, Dumontier S, Saulnier P, Chachaty E, Loubeyre C, Brugieres L, Andremont A: Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. Clinical Microbiology and Infection (1996) 2:192-201
14. 14. Papanicolaou GA, Meyers BR, Meyers J, Mendelsohn MH, Lou W, Emre S, Sheiner P, Miller C: Nosocomial Infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clinical Infectious Diseases (1996) 23:760-766
15. 15. Simjee S, Gill MJ: Gene transfer, gentamicin resistance and enterococci. Journal of Hospital Infection (1997) 36:249-259
16. 16. Van Tiel FH, Van den Boogaard AE: In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci from humans and animals. Journal of Antimicrobial Chemotherapy (1997) 40:733-734
17. 17. Mercier RC, Penzak SR, Rybak MJ: In vitro activities of an investigational quinolone, glycycycline, glycopeptide, streptogramin and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy (1997) 41:2573-2575
18. 18. Baptista M, Depardieu F, Courvalin P, Arthur M: Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy (1996) 40:2291-2295
19. 19. Arthur M, Molinas C, Depardieu F, Courvalin P: Characterisation of Tn 1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM 4147. Journal of Bacteriology (1993) 175:117-127
20. 20. Leclercq R, Courvalin P: Resistance to glycopeptides in enterococci. Clinical Infectious Diseases (1997) 24:545-556
21. 21. Courvalin P: The Van alphabet. In: Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington DC (1998) p 622
22. 22. Perichon B, Reynolds P, Courvalin P: VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrobial Agents and Chemotherapy (1997) 41:2016-2018
23. 23. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K: Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the VanC genotype). Journal of Clinical Microbiology (1997) 35:3166-3170
24. 24. Bonafede ME, Carias LR, Rice LB: Enterococcal transposon Tn5384 : evolution of a composite transposon through co-integration of enterococcal and staphylococcal plasmids. Antimicrobial Agents and Chemotherapy (1997) 41:1854-1858
25. 25. Noskin GA, Stosor V, Cooper I, Peterson LR: Recovery of vancomycin resistant enterococci on fingertips and environmental surfaces. Infection Control and Hospital Epidemiology (1995) 16:577-581
26. 26. Power EG, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL: vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. Journal of Antimicrobial Chemotherapy (1995) 36:595-606
27. 27. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P: Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrobial Agents and Chemotherapy (1997) 41:24-29
28. 28. Ligozzi M, Lo Cascio G, Fontana R: vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans. Antimicrobial Agents and Chemotherapy (1998) 42:2055-2059
29. 29. Marshall CG, Lessard IA, Park I, Wright GD: Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrobial Agents and Chemotherapy (1998) 42:2215-2220
30. 30. Marshall CG, Broadhead G, Leskiw BK, Wright GD: D-Ala-D-Ala ligases from glycopeptide producing organisms are highly homologous to the enterococcal vancomycin resistance ligases VanA and VanB. Proceedings of the National Academy of Sciences of the USA. (1997) 94:6480-6483
31. 31. Boisivon A, Thibault M, Leclercq R: The College de Bacteriologie-Virologie-Hygiene des Hopiteaux Genereaux Français. Colonisation by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French hospitals. Clinical Microbiology and Infection (1997) 3:175-179
32. 32. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN: Evaluation and characterisation of multiresistant Enterococcus faecium from 12 US medical centers. Journal of Clinical Microbiology (1994) 32:2840-2842
33. 33. Endtz HP, Van den Braak N, Van Belkum A, Kluytmans JAJW, Koeleman JGM, Spanjaard L, Voss A, Weersink AJL, Vandenbroucke-Grauls CMJE, Buiting AGM, Van Duin A, Verbrugh HA: Faecal carriage of vancomycin-resistant enterococci in hospitalised patients and those living in the Netherlands. Journal of Clinical Microbiology (1997) 35:3026-3031
34. 34. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE: Vancomycin-resistant enterococci from nosocomial, community and animal sources in the United States. Antimicrobial Agents and Chemotherapy (1996) 40:2605-2609
35. 35. Jordens JZ, Bates J, Griffiths DT: Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy (1994) 34:515-528
36. 36. Gordts B, Van Landuyt H, Leven M, Vandamme P, Goossens H: Vancomycin-resistant enterococci colonising the intestinal tract of hospitalized patients. Journal of Clinical Microbiology (1995) 33:2842-2846
37. 37. Van den Boogaard AE, Stobberingh EE: Time to ban all antibiotics as animal growth promoters? Lancet (1996) 31:619
38. 38. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R: Influence of oral glycopeptides on the faecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. Journal of Infectious Diseases (1996) 173:1129-1136
39. 39. Kirst HA, Thompson DG, Nicas II: Historical yearly usage of vancomycin. Antimicrobial Agents and Chemotherapy (1998) 42:1303-1304
40. 40. Pensack JM, Wang GT, Simkins KL: Avoparcin, a growth promoting feed antibiotic for broiler chickens. Poultry Sciences (1982) 61:1009-1012
41. 41. Leeson S, Summers JD, Ferguson AE: Efficacy of avoparcin as a growth promotor for broiler chicken. Canadian Journal of Animal Sciences (1980) 60:275-279
42. 42. Aarestrup FM: Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microbial Drug Resistance (1995) 3:255-257
43. 43. Robredo B, Singh KV, Baquero F, Murray BE, Torres C: From vanA Enterococcus hirae to vanA Enterococcus faecium: a study of feed supplementation with avoparcin and tylosin in young chicken. Antimicrobial Agents and Chemotherapy (1999) 43:1137-1143
44. 44. Van den Braak N, Van Belkum A, Van Keulen M, Vliegenthart J, Verbrugh HA, Endtz HP: Molecular characterisation of vancomycin-resistant enterococci from hospitalised patients and poultry products in the Netherlands. Journal of Clinical Microbiology (1998) 36:1927-1932
45. 45. Bates J, Jordens Z, Selkon JB: Evidence for an animal origin of vancomycin-resistant enterococci. Lancet (1993) 342:490-491
46. 46. Bates J, Jordens Z, Griffiths DT: Farm animals as a putative reservoir for vancomycin-resistant enterococci infection in man. Journal of Antimicrobial Chemotherapy (1994) 34:507-516
47. 47. Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarfe JH: Epidemiology of an outbreak due to glycopeptide resistant Enterococcus faecium on a leukemia unit. Journal of Hospital Infection (1996) 34:171-182
48. 48. Klare I, Heier H, Claus H, Witte W: Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiology Letters (1995) 80:23-29
49. 49. Klare I, Heier H, Claus H, Reisbrodt R, Witte W: VanA mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiology Letters (1995) 347:165-171
50. 50. Van Belkum A, Van den Braak N, Thomassen R, Verbrugh HA, Endtz HP: Vancomycin-resistant enterococci in cats and dogs. Lancet (1996) 348:1038-1039
51. 51. DeVriese LA, Leven M, Goossens H, Vandamme P, Pot B, Hommez J, Haesebrouck F: Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrobial Agents and Chemotherapy (1996) 40:2285-2287
52. 52. Van den Boogaard AE, Jensen LB, Stobberingh EE: Vancomycin-resistant enterococci in turkeys and farmers. New England Journal of Medicine (1997) 337:1558-1559
53. 53. Moller-Aarestrup F: Association between decreased susceptibility to a new antibiotic for treatment of human disease, everninomycin (SCH27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin. Microbial Drug Resistance (1998) 4:137-141
54. 54. Schouten MA, Voss A, Hoogkamp-Korstanje JAA: VRE and meat. Lancet (1997) 349:1258
55. 55. Van den Braak N, Kreft D, Van Belkum A, Verbrugh HA, Endtz HP: Vancomycin-resistant enterococci in vegetarians. Lancet (1997) 350:146-147
56. 56. Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J: Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant enterococci Enterococcus faecium strains in a pediatric hospital. Journal of Clinical Microbiology (1991) 29:1888-1892
57. 57. Barbier N, Saulnier P, Chachaty E, Andremont A: Random amplified polymorphic DNA typing versus pulsed field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci. Journal of Clinical Microbiology (1996) 34:1096-1099
58. 58. Donabedian SM, Chow JW, Boyce JM, McCabe RE, Markowitz SM, Coudron PE, Kuritza A, Pierson CL, Zervos MJ: Molecular typing of ampicillin resistant non beta lactamase producing Enterococcus faecium isolates from diverse geographic areas. Journal of Clinical Microbiology (1992) 30:2757-2761
59. 59. Handwerger S, Skoble J, Discotto LF, Pucci M: Heterogeneity of the VanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrobial Agents and Chemotherapy (1995) 39:362-368
60. 60. Woodford N, Adebiyi AA, Palepou MI, Cookson BD: Diversity of VanA glycopeptide resistance elements in enterococci from humans and non-human sources. Antimicrobial Agents and Chemotherapy (1998) 42:502-508
61. 61. Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM: Molecular analysis of Tn1546 in Enterococcus faecium in isolates from animals and humans. Journal of Clinical Microbiology (1998) 36:437-442
62. 62. Morrison D, Woodford N, Cookson BD: Epidemic vancomycin-resistant Enterococcus faecium in the UK. Clinical Microbiology and Infections (1995) 1:146-147
63. 63. Pegues DA, Pegues CF, Hibberd PL, Ford DS, Hooper DC: Emergence and dissemination of a highly vancomycin-resistant VanA strain of Enterococcus faecium at a large teaching hospital. Journal of Clinical Microbiology (1997) 35:1565-1570
64. 64. Bonten MJM, Hayden MK, Nathan C, Rice TW, Weinstein RA: Stability of vancomycin-resistant enterococcal genotypes isolated from long term colonised patients. Journal of Infectious Diseases (1998) 177:378-382
65. 65. Willems R, Tops J, Van den Braak N, Van Belkum A, Mevius D, Hendriks G, Van Santen-Verheuvel M, Van den Embden J: Molecular diversity and evolutionary relationship of Tn1546-like elements in enterococci from man in animals. Antimicrobial Agents and Chemotherapy (1998) 43:483-491
66. 66. Woodford N, Chadwick PR, Morrison D, Cookson BD: Strains of glycopeptide resistant Enterococcus faecium can alter their van genotype during an outbreak. Journal of Clinical Microbiology (1997) 35:2966-2968
67. 67. Petts DN, Noble WC, Howell SA: Potential for gene transfer among enterococci from a single patient and the possibility of confounding typing results. Journal of Clinical Microbiology (1997) 35:1722-1727
68. 68. Noble WC, Virani Z, Cree RGA: Co-transfer of vancomycin and other resistant genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters (1992) 93:195-198
69. 69. Centers for Disease Control and Prevention: Interim guides for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morbidity and Mortality Weekly Report (1997) 46:626-635
70. 70. Hiramatsu K, Aritaka N, Kawasaki S, Hosoda S, Hori S, Fukuchi Y, Kobayashi I: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (1997) 350:1670-1673
71. 71. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, Clark NC, Hiramatsu K: Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. Journal of Clinical Microbiology (1998) 36:1020-1027
72. 72. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy (1997) 40:135-136
73. 73. Centers for Disease Control: Staphylococcus aureus with reduced susceptibility to vancomycin. Morbidity and Mortality Weekly Report (1997) 46:765-766
74. 74. Ploy MC, Greland C, Martin C, de Lumley L, Dennis F: First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet (1998) 351:212
75. 75. Howe RA, Bowker KE, Walsh TR, Feest TG, McGowan AP: Vancomycin resistance in Staphylococcus aureus. Lancet (1998) 351:602
76. 76. Van den Braak N, Van Belkum A, Te Witt R, Verbrugh HA, Endtz HP: Glycopeptide resistance among Staphylococcus spp. Journal of Antimicrobial Chemotherapy (1998) 42:676-677
77. 77. Sieradzki K, Villary P, Tomasz A: Decreased susceptibility to teicoplanin and vancomycin among coagulase negative methicillin resistant clinical isolates of staphylococci. Antimicrobial Agents and Chemotherapy (1998) 42:100-107
78. 78. Farrag N, Eltringham I, Liddy H: Vancomycin-dependent Enterococcus faecalis. Lancet (1997) 348:1581-1582
79. 79. Dever LL, Smith SM, Handwerger S, Eng RHK: Vancomycin-dependent Enterococcus faecalis isolated from stool following oral vancomycin therapy. Journal of Clinical Microbiology (1995) 33:2770-2773
80. 80. Hanaki H, Labischinski H, Inaba Y, Konde N, Murekami H, Hiramatsu K: Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus Mu50. Journal of Antimicrobial Chemotherapy (1998) 42:415-420
81. 81. Woodford N: Glycopeptide-resistant enterococci: a decade of experience. Journal of Medical Microbiology (1998) 47:849-862
82. 82. The Hospital Infection Control Practices Advisory Committee: Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). American Journal of Infection Control (1995) 23:87-94
83. 83. Angluin AM, Klym B, Byers KE, Scheld WM, Farr BM: Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin resistant E. faecium. Archives of Internal Medicine (1997) 157:1132-1136
84. 84. Ministry of Agriculture, Fisheries and Food: A review of antimicrobial resistance in the food chain. Technical Report, MAFF Publications, London (1998)
85. 85. Health Council of the Netherlands, Committee on Antimicrobial Growth Promotors: Antimicrobial growth promotors. Health Council of the Netherlands, Rijswijk (1998) Publication no. 1998/15
86. 86. European Commission: A ban on the use of some antibiotics in animal feed. European Union, Brussels Press release 10 December 1998
87. 87. Katz L, Chu DT, Reich K: Bacterial genomics and the search for novel antibiotics. In: Platner JJ (ed): Annual reports in medicinal chemistry. Academic Press, New York (1997):121-130
88. 88. Hamilton-Miller JMT: Think like a bacterium: a helpful concept to prolong the antibiotic era? Clinical Microbiology and Infection (1998) 4:177-178
89. 89. Witte W: Medical consequences of antibiotic use in agriculture. Science (1998) 279:996-997